TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1808764
国際登録日2024-07-29
区分第5類(薬剤)
商品役務Pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations for the treatment of inflammatory diseases; drugs for medical purposes; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; stem cells; pharmaceutical preparations for treating epidermal problems; antibacterial pharmaceuticals.
基礎出願番号
基礎出願日
基礎出願国
出願人SCM Lifescience, Inc.
OCRテキストSTIEMYNGLA
OCRテキスト2STEMYNGLA
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

SCM Lifescience, Inc.
STEMYNGLA
3か月前
SCM Lifescience, Inc.
STEMPRUVI
3か月前
SCM Lifescience, Inc.
GOVAHOD
3か月前
Novo Nordisk A/S
Zilconyc
3か月前
NUTRAVALIA
LUXEOL
1か月前
Boehringer Ingelheim International GmbH
3か月前
Celsius Live Fit International Designated Activity Company
21日前
Biocomposites International Limited
SYNICEM
3か月前
XENON PHARMACEUTICALS INC.
XENON
3か月前
BOYAN IVANOV ANASTASOV
3か月前
HuonsLab Co., Ltd.
HYDIFFUZE
3か月前
Novartis AG
21日前
Novartis AG
21日前
NOVARTIS AG
21日前
Novartis AG
21日前
Celsius Live Fit International Designated Activity Company
21日前
Nordic Bioscience A/S
nordicEndotrophin
3か月前
Nant Holdings IP, LLC
21日前
Nant Holdings IP, LLC
21日前
BLUE ORIGIN MANAGEMENT CONSULTANT PTE. LTD.
OH! SOME
3か月前
Neurotech Pharmaceuticals, Inc.
3か月前
Neurotech Pharmaceuticals, Inc.
O neurotech PHARMACEUTICALS
3か月前
Nant Holdings IP, LLC
21日前
Neurotech Pharmaceuticals, Inc.
O neurotech
3か月前
Remix Therapeutics Inc.
REMIXTHERAPEUTICS
3か月前
Viela Bio, Inc.
DAXFYTRA
3か月前
Ollin Biosciences Inc.
OLLIN
3か月前
CELSIUS HOLDINGS, INC.
Metaplus
3か月前
Merck Sharp & Dohme B.V.
3か月前
Novo Nordisk A/S
Ziltanir
3か月前
Entasis Therapeutics (Ireland) Limited
21日前
Glanbia Nutritionals Limited
NURSEMATE
3か月前
Anthos Therapeutics, Inc.
XXIRIZO
3か月前
Anthos Therapeutics, Inc.
LOBEXXI
3か月前
Anthos Therapeutics, Inc.
XXIABEL
3か月前
Anthos Therapeutics, Inc.
DUXXIBEL
3か月前
続きを見る